REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 131 filers reported holding REPLIGEN CORP in Q4 2013. The put-call ratio across all filers is 2.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,287,989 | +13.6% | 83,567 | +1.1% | 0.01% | +10.0% |
| Q2 2023 | $11,692,659 | -22.4% | 82,657 | -7.6% | 0.01% | -23.1% |
| Q1 2023 | $15,063,843 | -14.8% | 89,474 | -14.3% | 0.01% | -13.3% |
| Q4 2022 | $17,684,430 | -16.6% | 104,450 | -7.8% | 0.02% | -25.0% |
| Q3 2022 | $21,203,000 | +33.5% | 113,320 | +15.9% | 0.02% | +33.3% |
| Q2 2022 | $15,877,000 | -17.2% | 97,767 | -4.2% | 0.02% | 0.0% |
| Q1 2022 | $19,186,000 | -39.1% | 102,005 | -14.2% | 0.02% | -28.6% |
| Q4 2021 | $31,502,000 | -2.1% | 118,949 | +6.8% | 0.02% | -12.5% |
| Q3 2021 | $32,187,000 | +44.9% | 111,376 | +0.1% | 0.02% | +41.2% |
| Q2 2021 | $22,211,000 | -12.3% | 111,265 | -14.6% | 0.02% | -10.5% |
| Q1 2021 | $25,319,000 | +3.7% | 130,233 | +2.2% | 0.02% | 0.0% |
| Q4 2020 | $24,427,000 | +38.1% | 127,471 | +6.4% | 0.02% | +18.8% |
| Q3 2020 | $17,684,000 | +22.6% | 119,856 | +2.7% | 0.02% | +14.3% |
| Q2 2020 | $14,424,000 | +27.3% | 116,693 | -0.5% | 0.01% | 0.0% |
| Q1 2020 | $11,327,000 | -34.5% | 117,332 | -37.2% | 0.01% | -12.5% |
| Q4 2019 | $17,288,000 | +98.3% | 186,894 | +64.4% | 0.02% | +77.8% |
| Q3 2019 | $8,718,000 | +9.9% | 113,673 | +23.1% | 0.01% | 0.0% |
| Q2 2019 | $7,935,000 | +34.9% | 92,323 | -7.3% | 0.01% | +28.6% |
| Q1 2019 | $5,882,000 | +10.6% | 99,568 | -1.3% | 0.01% | 0.0% |
| Q4 2018 | $5,320,000 | -6.9% | 100,868 | -2.1% | 0.01% | 0.0% |
| Q3 2018 | $5,717,000 | +14.8% | 103,081 | -2.6% | 0.01% | 0.0% |
| Q2 2018 | $4,980,000 | +9.9% | 105,859 | -15.5% | 0.01% | +16.7% |
| Q1 2018 | $4,530,000 | +1.3% | 125,214 | +1.6% | 0.01% | 0.0% |
| Q4 2017 | $4,473,000 | -4.7% | 123,300 | +0.6% | 0.01% | -14.3% |
| Q3 2017 | $4,696,000 | -6.0% | 122,548 | +1.6% | 0.01% | -12.5% |
| Q2 2017 | $4,998,000 | +20.3% | 120,600 | +2.2% | 0.01% | +14.3% |
| Q1 2017 | $4,154,000 | +9.5% | 118,000 | -4.1% | 0.01% | +16.7% |
| Q4 2016 | $3,794,000 | -2.8% | 123,100 | -4.8% | 0.01% | 0.0% |
| Q3 2016 | $3,904,000 | +3.3% | 129,300 | -6.4% | 0.01% | 0.0% |
| Q2 2016 | $3,781,000 | -1.1% | 138,200 | -3.0% | 0.01% | 0.0% |
| Q1 2016 | $3,822,000 | -27.6% | 142,500 | -23.7% | 0.01% | -25.0% |
| Q4 2015 | $5,282,000 | -5.6% | 186,700 | -7.1% | 0.01% | -20.0% |
| Q3 2015 | $5,595,000 | -32.5% | 200,900 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $8,291,000 | +52.1% | 200,900 | -6.1% | 0.01% | +50.0% |
| Q1 2015 | $5,452,000 | 0.0% | 214,054 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $5,452,000 | +38.5% | 214,054 | +8.2% | 0.01% | +60.0% |
| Q3 2014 | $3,937,000 | -12.7% | 197,753 | -0.1% | 0.01% | -16.7% |
| Q2 2014 | $4,509,000 | +78.8% | 197,854 | +6.3% | 0.01% | +50.0% |
| Q1 2014 | $2,522,000 | -3.2% | 186,181 | -8.0% | 0.00% | 0.0% |
| Q4 2013 | $2,606,000 | +54.0% | 202,343 | +32.6% | 0.00% | +33.3% |
| Q3 2013 | $1,692,000 | +45.6% | 152,600 | +8.2% | 0.00% | +50.0% |
| Q2 2013 | $1,162,000 | – | 141,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |